A detailed history of Fmr LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Fmr LLC holds 133,936 shares of MXCT stock, worth $211,618. This represents 0.0% of its overall portfolio holdings.

Number of Shares
133,936
Previous 1,935,181 93.08%
Holding current value
$211,618
Previous $4.22 Million 95.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$1.27 - $2.33 $2.29 Million - $4.2 Million
-1,801,245 Reduced 93.08%
133,936 $211,000
Q2 2025

Aug 14, 2025

SELL
$2.04 - $2.92 $2.06 Million - $2.95 Million
-1,009,789 Reduced 34.29%
1,935,181 $4.22 Million
Q1 2025

May 12, 2025

SELL
$2.73 - $5.1 $523,616 - $978,185
-191,801 Reduced 6.11%
2,944,970 $8.04 Million
Q4 2024

Feb 13, 2025

BUY
$3.23 - $4.43 $498,137 - $683,203
154,222 Added 5.17%
3,136,771 $13 Million
Q3 2024

Nov 13, 2024

SELL
$3.68 - $5.06 $1.61 Million - $2.21 Million
-437,232 Reduced 12.79%
2,982,549 $11.6 Million
Q2 2024

Aug 13, 2024

SELL
$3.63 - $5.0 $104,798 - $144,350
-28,870 Reduced 0.84%
3,419,781 $13.4 Million
Q1 2024

May 13, 2024

BUY
$3.94 - $5.38 $2.42 Million - $3.31 Million
614,936 Added 21.7%
3,448,651 $14.4 Million
Q4 2023

Feb 13, 2024

BUY
$2.6 - $5.24 $7.36 Million - $14.8 Million
2,831,312 Added 117824.05%
2,833,715 $13.3 Million
Q3 2023

Nov 13, 2023

BUY
$3.02 - $5.1 $3,086 - $5,212
1,022 Added 74.0%
2,403 $7,000
Q2 2023

Aug 11, 2023

SELL
$3.69 - $5.35 $4,280 - $6,206
-1,160 Reduced 45.65%
1,381 $6,000
Q1 2023

May 11, 2023

SELL
$4.03 - $5.89 $9,667 - $14,130
-2,399 Reduced 48.56%
2,541 $12,000
Q4 2022

Feb 13, 2023

SELL
$4.92 - $7.4 $293,743 - $441,809
-59,704 Reduced 92.36%
4,940 $26,000
Q3 2022

Nov 10, 2022

BUY
$4.52 - $6.51 $9,564 - $13,775
2,116 Added 3.38%
64,644 $420,000
Q2 2022

Aug 12, 2022

BUY
$3.59 - $6.81 $7,118 - $13,504
1,983 Added 3.28%
62,528 $296,000
Q1 2022

May 13, 2022

BUY
$5.26 - $10.84 $318,466 - $656,307
60,545 New
60,545 $423,000

Others Institutions Holding MXCT

About MAXCYTE, INC.


  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $161M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.